May 3, 2011 (PRN): Theracos, Inc., a privately held biotechnology company, announced today that it has relocated the company’s offices from Sunnyvale, California to Marlborough, Massachusetts.

Dr. Albert Collinson, Theracos President and CEO, indicated that the California offices were closed effective May 1, 2011. The Company’s new offices are located at 225 Cedar Hill Rd, Suite 200, Marlborough, MA.

About Theracos:

Theracos, Inc. is a privately held pharmaceutical research and development company located in Marlborough, Massachusetts. Theracos develops, acquires, and supports research programs in inflammation, metabolism, and depression through research activities throughout the world. Theracos establishes the clinical efficacy of its therapeutic candidates through multicenter international trials closely managed by a senior team of investigators. [Wired by: PressReleaseNetwork.com]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.